Affomix, University of Montreal Pharmacogenomics Centre, Montreal Heart Institute deal

The parties will discover and produce biomarkers for use in cardiovascular diagnostics. Affomix will contribute its reagents for proteomic profiling of specific cardiovascular targets. Further details...